Point mutations in the human MYO1E gene, encoding class I myosin Myo1e, are associated with focal segmental glomerulosclerosis (FSGS), a primary kidney disorder that leads to end-stage kidney disease. The gene discussed is MYO1E; the disease is focal segmental glomerulosclerosis.